Tisdag 8 September | 16:06:43 Europe / Stockholm
Est. tid*
2026-08-25 - Kvartalsrapport 2026-Q2
2026-04-17 - X-dag ordinarie utdelning CANATU 0.00 EUR
2026-04-16 - Årsstämma
2026-03-03 - Bokslutskommuniké 2025
2025-08-29 - Kvartalsrapport 2025-Q2
2025-05-16 - X-dag ordinarie utdelning CANATU 0.00 EUR
2025-05-15 - Årsstämma
2025-03-28 - Bokslutskommuniké 2024
2024-08-29 - Kvartalsrapport 2024-Q2
2024-06-20 - X-dag ordinarie utdelning CANATU 0.00 EUR
2024-06-19 - Årsstämma
2024-02-08 - Bokslutskommuniké 2023
2023-08-24 - Kvartalsrapport 2023-Q2
2023-06-26 - Årsstämma
2023-05-09 - X-dag ordinarie utdelning CANATU 0.00 EUR
2023-03-02 - Bokslutskommuniké 2022
2022-09-15 - Kvartalsrapport 2022-Q2
2022-05-18 - Årsstämma
2022-05-17 - X-dag ordinarie utdelning CANATU 0.00 EUR
LandFinland
ListaFirst North Finland
SektorIndustri
IndustriIndustriprodukter
Canatu är ett teknikbolag verksamt inom djupteknologi som skapar kolnanorör (Canatu CNT), relaterade produkter och tillverkningsutrustning för halvledar-, fordons- och medicinsk diagnostikindustri. Bolaget verkar genom två affärsmodeller, för det första genom egna reaktorer för att utveckla och tillverka CNT-produkter. För det andra säljer bolaget sina CNT-reaktorer och licensierar dess relaterade teknologi, för att kunder ska kunna producera produkterna själva under en begränsad licens.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

Canatu Oyj - Managers' transactions – Vesterinen, Mikko

2026-08-28 13:05:00

Canatu Plc Managers’ transactions 28.8.2026 at 14:05 p.m. EEST

Canatu Oyj - Managers' transactions – Vesterinen, Mikko

 ____________________________________________

Person subject to the notification requirement

Name: Vesterinen, Mikko Juhani

Position: Chief Financial Officer

Issuer: Canatu Oyj

LEI: 743700CKOP7IHGI98B12

Notification type: INITIAL NOTIFICATION

Reference number: 171055/5/4

____________________________________________

Transaction date: 2026-08-27

Venue: FSME

Instrument type: SHARE

ISIN: FI4000512496

Nature of the transaction: ACQUISITION

Transaction details

(1): Volume: 24 Unit price: 5.4 EUR

(2): Volume: 149 Unit price: 5.42 EUR

(3): Volume: 200 Unit price: 5.43 EUR

(4): Volume: 200 Unit price: 5.43 EUR

(5): Volume: 696 Unit price: 5.44 EUR

(6): Volume: 28 Unit price: 5.44 EUR

(7): Volume: 200 Unit price: 5.46 EUR

(8): Volume: 200 Unit price: 5.46 EUR

(9): Volume: 31 Unit price: 5.46 EUR

(10): Volume: 28 Unit price: 5.46 EUR

(11): Volume: 380 Unit price: 5.48 EUR

(12): Volume: 766 Unit price: 5.49 EUR

(13): Volume: 200 Unit price: 5.49 EUR

(14): Volume: 338 Unit price: 5.5 EUR

(15): Volume: 266 Unit price: 5.425 EUR

(16): Volume: 253 Unit price: 5.425 EUR

(17): Volume: 270 Unit price: 5.49 EUR

(18): Volume: 229 Unit price: 5.5 EUR

(19): Volume: 876 Unit price: 5.5 EUR

(20): Volume: 876 Unit price: 5.5 EUR

(21): Volume: 200 Unit price: 5.5 EUR

(22): Volume: 676 Unit price: 5.5 EUR

(23): Volume: 324 Unit price: 5.5 EUR

(24): Volume: 353 Unit price: 5.52 EUR

(25): Volume: 250 Unit price: 5.52 EUR

(26): Volume: 1,005 Unit price: 5.53 EUR

(27): Volume: 200 Unit price: 5.55 EUR

(28): Volume: 782 Unit price: 5.55 EUR

Aggregated transactions (28):

Volume: 10,000 Volume weighted average price: 5.49283 EUR

Additional information

Mikko Vesterinen, CFO, mikko.vesterinen@canatu.com

Dr. Maximilian Slawinski, CEO, maximilian.slawinski@canatu.com

Certified adviser

DNB Carnegie Investment Bank AB (publ), tel. +46 (0) 8 588 685 70

About Canatu

Canatu (CANATU, Nasdaq First North, Finland) is a deep technology scaleup company creating advanced carbon nanotubes (Canatu CNTs), related products, and manufacturing equipment for the semiconductor, robotics, mobility and defense, and medical diagnostics industries. Canatu partners with forerunner companies, together transforming products for better tomorrows with nano carbon.

Canatu’s versatile platform technology has broad potential applications. Its current core includes CNT membranes for extreme ultraviolet (EUV) processes in the semiconductor industry, enabling more effective manufacturing of the most advanced chips. Additionally, electrochemical sensors for medical diagnostics are in the development phase. Canatu’s patented CNT reactors and Ddry Ddeposition by CanatuTM method yield clean and pristine CNTs. The company operates through two business models: selling CNT products directly, as well as selling CNT reactors and licensing the related technology so that customers can produce CNT products under a limited license.

Headquartered in Finland, Canatu also operates in the US, Japan and Taiwan. Founded in 2004 as a spin-off from Aalto University’s Nanomaterials Group, Canatu currently has 182 full-time equivalent employees representing over 35 nationalities, with nearly 20% holding or pursuing doctorates (as of 30 June 2026). Discover more at www.canatu.com and follow us on LinkedIn.